EUVIMEDOdkrijte EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY 4.0

Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis

Noémie Fournier, Panagiotis Antiochos, Baris Gencer, Anna Nowacka, Tamila Abdurashidova, Patrick Yerly, Philippe Meyer, Valentina Rancati, Zied Ltaief, Olivier Muller, Matthias Kirsch, Roger Hullin and 1 more

Clinical Transplantation · 2026-11 · 40 (11)

DOI: 10.1111/ctr.70742 ↗

At a glance

Systematische Übersicht in Clinical Transplantation, published online on 2026-11-07. Written by Noémie Fournier and 12 co-authors. Institution: Division of Cardiology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland. Major MEDLINE topics: Heart Transplantation, Aspirin, Graft Rejection, Postoperative Complications. 23 references. The full text is freely available (open access, CC BY 4.0).

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Background

Cardiac allograft vasculopathy (CAV) remains a major cause of late graft failure and morbidity among heart transplant (HTx) recipients. Aspirin is currently assigned a Class IIb recommendation for CAV prevention, reflecting the limited evidence supporting its clinical benefit. We conducted a systematic review and meta‐analysis to assess the association between aspirin use and clinical outcomes in HTx recipients (PROSPERO ID: CRD420261399873).

Methods

Outcomes of interest included all‐cause mortality and CAV‐related clinical outcomes (graft dysfunction or CAV‐related death). Literature searches were conducted through December 2025 in PubMed and EMBASE. Studies comparing HTx recipients treated with aspirin versus no aspirin were included. Hazard ratios (HRs) and 95% confidence intervals (CIs) were meta‐analyzed across studies.

Results

Five observational studies were included, comprising four adult cohorts and one pediatric cohort. Participants were predominantly male (66.6%), with a mean age of ≈50 years in the four adult studies and 7.4 years in the sole pediatric study. Aspirin use was associated with significantly lower all‐cause mortality (four studies, HR 0.31 [95% CI: 0.15–0.67]). No statistically significant association was observed with CAV‐related clinical outcomes (HR 0.42 [95% CI: 0.10–1.77]).

Conclusions

In HTx recipients, aspirin use was associated with lower all‐cause mortality, while no significant association was observed in the exploratory analysis of CAV‐related clinical outcomes. These findings should be interpreted cautiously given the observational design, substantial heterogeneity, and potential residual and time‐related biases. Prospective studies are needed to determine the efficacy and safety of aspirin after HTx.

Subjects

MeSH terms (MEDLINE)

Heart TransplantationAspirinGraft RejectionPostoperative ComplicationsVascular DiseasesHumansGraft SurvivalPrognosisRisk FactorsAllograftsSurvival Rate

Author keywords

Aspirincardiac allograft vasculopathyheart transplantmeta‐analysis

Substances

Aspirin

Authors and institutions

  • Division of Cardiology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
  • Division of Cardiac Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
  • Division of Cardiology, Geneva University Hospitals (HUG), University of Geneva (UNIGE), Geneva, Switzerland.
  • Division of Anesthesiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Department of Adult Intensive Care Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.

Cite

APA

Fournier, N., Antiochos, P., Gencer, B., Nowacka, A., Abdurashidova, T., Yerly, P., Meyer, P., Rancati, V., Ltaief, Z., Muller, O., Kirsch, M., Hullin, R., & Lu, H. (2026). Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis. Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70742

Vancouver

Fournier N, Antiochos P, Gencer B, Nowacka A, Abdurashidova T, Yerly P, et al. Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis. Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70742

BibTeX
@article{Fournier2026,
  author = {Fournier, Noémie and Antiochos, Panagiotis and Gencer, Baris and Nowacka, Anna and Abdurashidova, Tamila and Yerly, Patrick and Meyer, Philippe and Rancati, Valentina and Ltaief, Zied and Muller, Olivier and Kirsch, Matthias and Hullin, Roger and Lu, Henri},
  title = {Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta‐analysis},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1111/ctr.70742}
}
Start for free →